|
BCORL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.599100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.220200E-02 |
| Normal-vs-Stage2 |
1.433990E-04 |
| Normal-vs-Stage3 |
1.170140E-04 |
| Normal-vs-Stage4 |
2.357700E-04 |
| Stage1-vs-Stage2 |
9.642800E-03 |
| Stage1-vs-Stage3 |
1.215920E-02 |
| Stage1-vs-Stage4 |
1.995640E-02 |
| Stage2-vs-Stage3 |
4.622800E-01 |
| Stage2-vs-Stage4 |
5.759000E-01 |
| Stage3-vs-Stage4 |
8.798600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.788300E-04 |
| Normal-vs-AfricanAmerican |
6.564300E-04 |
| Normal-vs-Asian |
5.110200E-01 |
| Caucasian-vs-AfricanAmerican |
2.129400E-01 |
| Caucasian-vs-Asian |
7.060500E-02 |
| AfricanAmerican-vs-Asian |
2.909700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.399550E-04 |
| Normal-vs-Female |
2.254400E-02 |
| Male-vs-Female |
5.600100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.104350E-02 |
| Normal-vs-Age(41-60Yrs) |
4.979200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.167300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.954100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.200800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.459000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.086200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.428200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.514400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.956000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.743000E-01 |
| Normal-vs-Grade 2 |
1.558130E-02 |
| Normal-vs-Grade 3 |
8.370400E-04 |
| Normal-vs-Grade 4 |
1.63620000004361E-06 |
| Grade 1-vs-Grade 2 |
1.140390E-01 |
| Grade 1-vs-Grade 3 |
3.810200E-02 |
| Grade 1-vs-Grade 4 |
9.633400E-04 |
| Grade 2-vs-Grade 3 |
2.113000E-01 |
| Grade 2-vs-Grade 4 |
1.976280E-03 |
| Grade 3-vs-Grade 4 |
5.806000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.276000E-01 |
| Normal-vs-ccB subtype |
1.62567999999474E-05 |
| ccA subtype-vs-ccB subtype |
2.00209999999812E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.521530E-03 |
| Normal-vs-N1 |
3.018000E-02 |
| N0-vs-N1 |
5.812000E-01 |
|
|
